1. 1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine. (31st December 2020) Authors: Brar, Indira; Ruane, Peter; Ward, Douglas; Molina, Jean-michel; Mills, Anthony; Berhe, Mezgebe; Brinson, Cynthia; Rampogal, Moti; Benson, Paul; Henry, Keith; Huang, Hailin; Andreatta, Kristen; Martin, Hal Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results from the POLAR Study. (31st December 2020) Authors: Mills, Anthony; Richmond, Gary J; Newman, Cheryl; Osiyemi, Olayemi; Cade, Jerry; Brinson, Cynthia; De Vente, Jerome; Andany, Nisha; Margolis, David; Sutton, Kenneth; Wilches, Viviana; Roberts, Jeremy; McCoig, Cynthia C; Vandermeulen, Kati; Spreen, William Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1574Safety Profile of HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Analysis. (December 2014) Authors: Lalezari, Jacob; Latiff, Gulam H; Brinson, Cynthia; Echevarría, Juan; Treviño-Pérez, Sandra; Bogner, Johannes R; Stock, David; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1905. Real-World Insights into Quality Improvement across 11 HIV Clinics in the United States. (26th November 2018) Authors: Wohl, David Alain; Brinson, Cynthia; Hicks, Charles; Shalit, Peter; Hardy, W David; Carter, Jeffrey; Simone, Laura; Sapir, Tamar Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab. (4th December 2021) Authors: Gupta, Anil K; Rojas, Yaneicy Gonzalez; Juarez, Erick; Casal, Manuel Crespo; Moya, Jaynier; Falci, Diego Rodrigues; Sarkis, Elias H; Solis, Joel; Zheng, Hanzhe; Scott, Nicola; Cathcart, Andrea L; Hebner, Christy; Sager, Jennifer; Mogalian, Erik; Austin, Daren; Peppercorn, Amanda; Alexander, Eliza... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 537STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96. (December 2014) Authors: Creticos, Catherine; Brinson, Cynthia; Mcdonald, Cheryl; Segal-Maurer, Sorana; Brar, Indira; Wade, Barbara; Garner, Will; Porter, Danielle; De-Oertel, Shampa; Weinberg, Amy; Sparrow, Toni Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 540HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis. (December 2014) Authors: Brinson, Cynthia; Lalezari, Jacob; Latiff, Gulam H; Thompson, Melanie; Echevarría, Juan; Treviño-Pérez, Sandra; Stock, David; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 69. Incidence of metabolic complications among treatment-naïve adults living with HIV-1 randomized to B/F/TAF, DTG/ABC/3TC or DTG+F/TAF after 144 Weeks. (4th December 2021) Authors: Daar, Eric; Orkin, Chloe; Sax, Paul; Stephens, Jeffrey L; Koenig, Ellen; Clarke, Amanda; Baumgarten, Axel; Brinson, Cynthia; Ramgopal, Moti; Huang, Hailin; Farrow, Terry; Baeten, Jared; Hindman, Jason; Martin, Hal; Workowski, Kimberly Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 69. Incidence of metabolic complications among treatment-naïve adults living with HIV-1 randomized to B/F/TAF, DTG/ABC/3TC or DTG+F/TAF after 144 Weeks. (4th December 2021) Authors: Daar, Eric; Orkin, Chloe; Sax, Paul; Stephens, Jeffrey L; Koenig, Ellen; Clarke, Amanda; Baumgarten, Axel; Brinson, Cynthia; Ramgopal, Moti; Huang, Hailin; Farrow, Terry; Baeten, Jared; Hindman, Jason; Martin, Hal; Workowski, Kimberly Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 854. Long-term Outcomes of Participants on F/TAF for Pre-Exposure Prophylaxis: Results for 144 Weeks of Follow-Up in the DISCOVER Trial. (4th December 2021) Authors: Ramgopal, Moti; Ruane, Peter; Shao, Yongwu; Ebrahimi, Ramin; Kintu, Alex; Carter, Christoph C; Das, Moupali; Baeten, Jared; Brinson, Cynthia; Shalit, Peter; Mounzer, Karam Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗